Overview
Lukman Tijani is a Hematologist in Lubbock, Texas. Dr. Tijani is highly rated in 27 conditions, according to our data. His top areas of expertise are Lung Cancer, Small Cell Lung Cancer (SCLC), Neuroendocrine Tumor, Bone Marrow Aspiration, and Endoscopy.
His clinical research consists of co-authoring 20 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- EPO
- HMO
- PPO
- HMO
Accepted plan types not found. Please verify directly with the provider.
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- OTHER COMMERCIAL
Locations
602 Indiana Ave, Lubbock, TX 79415
3601 4th St, Lubbock, TX 79430
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
5 Clinical Trials
University Medical Center
Nicholas Cunha is a Hematologist and an Oncologist in Lubbock, Texas. Dr. Cunha is highly rated in 19 conditions, according to our data. His top areas of expertise are Multiple Myeloma, Pleuropulmonary Blastoma, Richter Syndrome, Chronic Lymphocytic Leukemia (CLL), and Bone Marrow Aspiration.
Rufus J. Mark M.D. P.A.
Kemnasom Nwanwene is a Hematologist in Lubbock, Texas. Her top areas of expertise are Leukocytosis, Lung Cancer, Autoimmune Hemolytic Anemia, and Non-Small Cell Lung Cancer (NSCLC).
Office
Rodney Stuart is a Hematologist in Lubbock, Texas. His top areas of expertise are Non-Muscle Invasive Bladder Cancer, Muscle Invasive Bladder Cancer, Anemia, and Gallbladder Disease.
Frequently Asked Questions about Dr. Lukman Tijani
How do I make an appointment with Dr. Lukman Tijani?
You can book an appointment with Dr. Lukman Tijani by calling their office at 806-775-8600. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Lukman Tijani a top-rated expert for Lung Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Lukman Tijani is classified as an Distinguished expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Lukman Tijani specialize in?
While Dr. Lukman Tijani is a Hematology, they have specific expertise in Lung Cancer, Small Cell Lung Cancer (SCLC), and Neuroendocrine Tumor. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. Lukman Tijani participate in research or clinical trials?
Yes. Dr. Lukman Tijani has published 20 articles and abstracts on conditions like Lung Cancer. You can view a list of Dr. Lukman Tijani's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Lukman Tijani accept my insurance?
Dr. Lukman Tijani accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 806-775-8600 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Lung CancerDr. Tijani isDistinguished. Learn about Lung Cancer.
- Neuroendocrine TumorDr. Tijani isDistinguished. Learn about Neuroendocrine Tumor.
- Non-Small Cell Lung Cancer (NSCLC)Dr. Tijani isDistinguished. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Pleuropulmonary BlastomaDr. Tijani isDistinguished. Learn about Pleuropulmonary Blastoma.
- Small Cell Lung Cancer (SCLC)Dr. Tijani isDistinguished. Learn about Small Cell Lung Cancer (SCLC).
- Advanced
- ALK-Positive Non-Small Cell Lung Cancer
- Antiphospholipid SyndromeDr. Tijani isAdvanced. Learn about Antiphospholipid Syndrome.
- Chromophobe Renal Cell CarcinomaDr. Tijani isAdvanced. Learn about Chromophobe Renal Cell Carcinoma.
- Clear Cell SarcomaDr. Tijani isAdvanced. Learn about Clear Cell Sarcoma.
- EGFR Positive Lung CancerDr. Tijani isAdvanced. Learn about EGFR Positive Lung Cancer.
- Factor V Leiden ThrombophiliaDr. Tijani isAdvanced. Learn about Factor V Leiden Thrombophilia.
- Experienced
- Acinic Cell Carcinoma of Salivary Glands
- Acute Hepatic Porphyria (AHP)Dr. Tijani isExperienced. Learn about Acute Hepatic Porphyria (AHP).
- Acute Mountain SicknessDr. Tijani isExperienced. Learn about Acute Mountain Sickness.
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Tijani isExperienced. Learn about Acute Myeloid Leukemia (AML).